SAM
ABBV icon

Scotia Asset Management’s AbbVie ABBV Stock Holding History

Scotia Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$3.63M Buy
81,179
+8,548
+12% +$379K 0.18% 57
2013
Q2 		$3M Buy
+72,631
New +$3.18M 0.16% 59

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Scotia Asset Management's ABBV Position: Q3 2013 in Review

Scotia Asset Management increased its AbbVie (ABBV) stake by 12% in Q3 2013, buying an estimated $379K and bringing the position to 81,179 shares worth $3.63M. The position accounts for 0.18% of the portfolio, ranked #57.

Scotia Asset Management first reported a position in ABBV in Q2 2013 and has held it in 2 quarters since. 1,296 funds tracked by Wall St. Rank hold ABBV as of Q3 2013.

  • Scotia Asset Management held 81,179 shares of AbbVie worth $3.63M as of Q3 2013.
  • Scotia Asset Management bought 8,548 AbbVie shares in Q3 2013, an estimated $379K.
  • AbbVie made up 0.18% of Scotia Asset Management's portfolio in Q3 2013, its #57 holding.
  • Scotia Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 2 quarters since.
  • 1,296 funds tracked by Wall St. Rank held AbbVie as of Q3 2013.

Based on Scotia Asset Management's 13F filing for Q3 2013, filed 14 Nov 2013.